| 1. American Thoracic Society statement:Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Resp. Crit. Care Med., 152, 1995, Suppl.: 77-120 |
| 2. British Thoracic Society: Current best practice for nebuliser treatment. Thorax, 52, 1997,(Suppl.2): 1-106 |
| 3. Brochard L., Mancebo J., Wysocki M.:Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N. Engl. J. Med., 333, 1995: 817-822 |
| 4. Grove A., Lipworth B. J., Reid P., et al.: Effects of regular salmeterol on lung function and exercise capacity in patients with chronic obstructive airways disease. Thorax, 1996: 689-693 |
| 5. Hubbard R. C., Ogushi F., Fells G. A., et al.:Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alfa1 antitrypsin rendering it ineffective as an inhibitor of neutrophil elastase. J. Clin. Invest., 80, 1987: 1289-1295 |
| 6. Janoff A.: Elastases and emphysema-current assessment of the protease-antiprotease hypothesis. Am. Rev. Respir. Dis., 132, 1985: 417-433 |
| 7. Montenegro H. D., Cherniack N. S.:In.: Callahan M. L.: Current therapy in emergency medicine. B. C. Decker, Toronto, 1987: 367-368 |
| 8. Nocturnal Oxygen Therapy Trial Group: Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. Ann. Intern. Med., 93, 1980: 391-398 |
| 9. Pride N. B.:Which smokers develop progressive airflow obstruction. Eur. J. Respir. Dis., 64, 1983,(Suppl 64): 79-84 |
| 10. Saetta M., Di Stephano A., Maestrelli P., et al.:Activated T lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am. Rev. Respir. Dis., 147,1993: 301-306 |
| 11. Siafakas N. M., Vermeire P., Pride N. B., et al.: Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur. Respir. J., 8, 1995: 1398-1420 |
| 12. The Combivent inhalation aerosol study:Combination of ipratropium and albuterol is more effective than either agent alone. Chest, 105,1994: 1411-1419 |
| 13. The COPD Guidelines Group of the Standards of Care Comittee of the BTS:BTS Guidelines for the Management of Chronic Obstructive Pulmonary Disease. Thorax, 52, 1997, Suppl. 5: 1-28 |
| 14. Thromboembolic Risk Factors Consensus Group:Risk and prophylaxis for venous thromboembolism in hospital patients. B.M.J., 305, 1992: 567-573 |
Tabulka 8
1. 2. 2000 0:00
Literatura